Close Menu

NEW YORK – The US Food and Drug Administration in March cleared the marketing of in vitro diagnostic tests from Roche Diagnostics, BioMérieux, Horiba, and others, according to the agency's website.

Roche Diagnostics received clearance for the Elecsys BRAHMS PCT electrochemiluminescence immunoassay, which runs on the firm's Elecsys and Cobas e immunoassay analyzers and measures procalcitonin levels in serum and plasma.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.